top of page

Enabling digital health, medical technologies, and care programs to secure economic validation. 

Turn your technology’s early health‑economic case into a clear, evidence‑based story that inspires investors, payers, and clinical partners.

Demonstrate robust health‑economic evidence into a clear value that drives payer trust, reimbursement approval, and long‑term market strategy.

Empower your medtech projects with seamless collaboration, deep data access, and rapid, evidence‑driven results.


What We Offer

Early Economic & Value Demonstration

Using early economic insights and adoption evidence, we help you demonstrate how your solution delivers better care and reduces costs for patients and providers. This clear value story builds investor confidence and helps you connect earlier and more effectively with hospitals and clinics.

Robust Health Economic Modelling

Through advanced data-driven modelling, we demonstrate how your solution performs against current care using three key analyses: budget impact modelling, cost‑effectiveness analysis, and cost‑benefit assessment.

Generate the evidence needed for reimbursement and HTA acceptance.

Your Health Economics Capacity

Ad‑hoc health economics support that helps partners deliver faster, deeper, and more complete results. With access to clinical practices and economic data, including treatment costs and claims across Switzerland, the EU, and the US - with a trusted KOL network across multiple therapeutic areas.  

Solutions We've Delivered

Each project is a testament to our commitment to quality, collaboration, and innovation.

Explore the impact we've made with our clients.​​

ISPOR Medical devices and digital health startups trends

ISPOR Health Economic Trends 2024-2025
Download Our Health Glossary

Medical Devices NIH SEED Innovator in the US reimbursement for startups

Medical Devices NIH SEED Innovator in the US reimbursement

  PaRIS study finally gives patients a global voice,  and reveals how well the Swiss health system,and value based healthcare

PaRIS study finally gives patients a global voice,  and reveals how well the Swiss health system is doing for chronic patients

Who We Are

Stepval is a health economics consulting boutique specializing in early-stage economic evaluation and health economic modeling for digital health solutions, medical devices, and personalized care programs.

Our differentiation lies in our therapeutic-area-specific service profiles, where internal domain experts engage at the earliest phase of client requests to deliver:

  • High-quality assessments aligned with payer and HTA requirements

  • Accelerated timelines through iterative model development

  • Efficiency gains via pre-validated analytic frameworks

Testimonials

"Stepval was great! Very responsive and quick without compromising quality"

A. Alnow, HTA director

Partners

R Studio health economics modelling
ISPOR, health economics in medical devices and digital health startups
Swiss startup association
healthtechpark_logo.png
Screenshot 2026-03-02 174859.jpg

Supported
by

Innosuisse and venture labs programms for medical devices and digital health startups
Patient reported outcomes health economics in switzerland
University of Zurich Startup hubs in medical devices and digital health
Nucleate for medical devices and digital health startups
Swiss Healthcare Startups health economics and reimbursement in Switzerland, reimbursement

Your News & Blog

Dive into the latest trends, research, and policy updates in health economics.

Our blog delivers data-driven analysis, expert opinions, and actionable knowledge, helping you navigate the evolving landscape of healthcare systems, costs, and outcomes.

Subscribe to our Newsletter

You will receive information about your regional healthcare systems every six months, along with exclusive trends in health economics.

Don't miss out!

bottom of page